AGIOS PHARMACEUTICALS INC
AGIO · NASDAQ
Updated at 2026-10-15 03:57:38
- Today's High
- $31.11
- Today’s Low
- $29.67
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $30.07
- Previous Close
- $30.97
- Volume
- 930.89K
- Market Cap
- $1.84B
- P/E Ratio
- --
- EPS
- $-7.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 88 SIDNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02139
- Country
- US
- Listing Date
- 2013-07-24
- Fiscal Year End
- December
- Shares Outstanding
- 59.47M
- CIK
- 0001439222
- Website
- www.agios.com
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$44.74M
2026-03-31
$20.74M
2025-12-31
$19.96M
2025-09-30
$12.88M
Operating Expenses
2026-06-30
$152.3M
2026-03-31
$128.08M
2025-12-31
$138.4M
2025-09-30
$126.69M
Net Income
2026-06-30
-$100.7M
2026-03-31
-$99.11M
2025-12-31
-$108.03M
2025-09-30
-$103.43M
Net Profit Margin
2026-06-30
-225.06%
2026-03-31
-477.73%
2025-12-31
-541.08%
2025-09-30
-803.05%
Earnings Per Share
2026-06-30
$-1.69
2026-03-31
$-1.69
2025-12-31
$-1.85
2025-09-30
$-1.78
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$109.2M
2026-03-31
-$97.74M
2025-12-31
-$107.78M
2025-09-30
-$102.05M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0.93%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $44.74M | $20.74M | $19.96M | $12.88M |
| Operating Expenses | $152.3M | $128.08M | $138.4M | $126.69M |
| Net Income | -$100.7M | -$99.11M | -$108.03M | -$103.43M |
| Net Profit Margin | -225.06% | -477.73% | -541.08% | -803.05% |
| Earnings Per Share | $-1.69 | $-1.69 | $-1.85 | $-1.78 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$109.2M | -$97.74M | -$107.78M | -$102.05M |
| Effective Tax Rate | -- | -- | 0.93% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.